Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Programable Albumin-Hitchhiking Nanobodies Enhance the Delivery of STING Agonists to Potentiate Cancer Immunotherapy.

Autor: Wilson J; Vanderbilt University., Kimmel B; Vanderbilt University., Arora K; Vanderbilt University., Chada N; Vanderbilt University., Bharti V; Vanderbilt University., Kwiatkowski A; Vanderbilt University., Finklestein J; Vanderbilt University., Hanna A; Vanderbilt University Medical Center., Arner E; Vanderbilt University Medical Center., Sheehy T; Vanderbilt University., Pastora L; Vanderbilt University., Yang J; Vanderbilt University Medical Center., Pagendarm H; Vanderbilt University., Stone P; Vanderbilt University., Taylor B; Vanderbilt University Medical Center., Hubert L; Vanderbilt University., Gibson-Corley K; Vanderbilt University Medical Center., May J, McLean J; Vanderbilt University., Rathmell J; Vanderbilt University Medical Center., Richmond A; Vanderbilt University Medical Center., Rathmell W; Vanderbilt University Medical Center., Balko J; Vanderbilt University Medical Center., Fingleton B; Vanderbilt University Medical Center., Hargrove-Wiley E; Vanderbilt University.

Publikováno v: Research square [Res Sq] 2024 May 08. Date of Electronic Publication: 2024 May 08.